# Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

> **NCT01250665** · — · UNKNOWN · sponsor: **Cantonal Hospital of St. Gallen** · enrollment: 65 (estimated)

## Conditions studied

- Multiple Sclerosis
- Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01250665
- **Lead sponsor:** Cantonal Hospital of St. Gallen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2010-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250665, "Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01250665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*